Vaccinex, Inc.
General ticker "VCNX" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $2.2M (TTM average)
Vaccinex, Inc. does not follow the US Stock Market performance with the rate: -0.9%.
Estimated limits based on current volatility of 20.4%: low 0.48$, high 0.73$
Factors to consider:
- Total employees count: 38 as of 2022
- Company does not operate outside North America (retrieved using AI)
- Top business risk factors: Going concern, Commercialization challenges, Liquidity and credit risks, Economic downturns and volatility, Regulatory and compliance
- Current price 36.7% below estimated low
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [1.10$, 3.69$]
- 2025-12-31 to 2026-12-31 estimated range: [0.86$, 2.76$]
Financial Metrics affecting the VCNX estimates:
- Positive: with PPE of -0.1 at the end of fiscal year the price was low
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -695.42 <= 0.33
- Negative: Shareholder equity ratio, % of -95.84 <= 18.93
- Positive: Interest expense per share per price, % of 0.09 <= 0.79
- Negative: Industry earnings per price (median), % of -16.34 <= 0
- Negative: negative Net income
Short-term VCNX quotes
Long-term VCNX plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $0.10MM | $0.57MM | $0.60MM |
| Operating Expenses | $20.01MM | $23.45MM | $19.34MM |
| Operating Income | $-19.91MM | $-22.89MM | $-18.73MM |
| Non-Operating Income | $0.09MM | $2.63MM | $0.10MM |
| Interest Expense | $0.00MM | $0.00MM | $0.00MM |
| R&D Expense | $13.98MM | $16.57MM | $12.54MM |
| Income(Loss) | $-19.82MM | $-20.25MM | $-18.63MM |
| Profit(Loss)* | $-19.72MM | $-20.25MM | $-18.63MM |
| Stockholders Equity | $5.19MM | $-2.31MM | $-2.49MM |
| Assets | $7.98MM | $3.63MM | $2.60MM |
| Operating Cash Flow | $-19.07MM | $-17.23MM | $-16.19MM |
| Capital expenditure | $0.10MM | $0.07MM | $0.02MM |
| Investing Cash Flow | $-0.10MM | $-0.07MM | $-0.02MM |
| Financing Cash Flow | $16.98MM | $12.45MM | $15.78MM |
| Earnings Per Share** | $-97.59 | $-43.68 | $-8.88 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.